University of Basrah
  • Register
  • Login
  • العربیة

The Medical Journal of Basrah University

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 36, Issue 2
  3. Author

Current Issue

By Issue

By Subject

Keyword Index

Author Index

Indexing Databases XML

About Journal

Aims and Scope

Editorial Board

Advisory Board

Editorial Staff

Facts and Figures

Publication Ethics

Indexing and Abstracting

Related Links

Peer Review Process

News

Effect of Azithromycin in Treatment of Cutaneous Leishmaniasis

    Dindar S Qurtas

The Medical Journal of Basrah University, 2018, Volume 36, Issue 2, Pages 97-102
10.33762/mjbu.2018.159464

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction: Leishmaniasis is a vector born protozoal infection. Cutaneous leishmaniasis outbreak occurred during 2014 in Erbil governorate, Kurdistan-Iraq. First choice of its treatment is pentavalent antimony. Other options of treatment are available. Azithromycin is used as trial to be effective but human studies are lacking.
Patients and Methods: Prospective randomized open labeled interventional study conducted on 63 patients. The sample divided in to two groups. Group A received only intra-lesional sodium stibogluconate and the group B received combination therapy of intra-lesional sodium stibogluconate and azithromycin 500 mg orally. Follow up done for lesions’ healing at 6th week and at the end of 8th week of therapy.
Results: Nodular lesions were dominant morphology among the Lesions (71.5%). Lesions mostly were ulcerated (59%). Mean duration of lesions were 3 ± 1.1 and 2.4 ± 1.8 weeks in patients of group A and B respectively. At 6th week in patients of group A, there were 13(41.9%) patients with complete healing of the lesions, while in group B it was found in 23(71.8%) patients. At the end of 8th week group A patients showed complete healing in 21(67.7%) patients while in patients of group B complete healing found in 27(84.3%).
Conclusions: Results of this study concludes that combination therapy of azithromycin and intra-lesional sodium stibogluconate provides more therapeutic effect if compared with the effect of intra-lesional sodium stibogluconate alone.
.
Keywords:
    Cutaneous leishmaniasis intra lesional sodium stibogluconate Azithromycin
  • PDF
  • XML
(2018). Effect of Azithromycin in Treatment of Cutaneous Leishmaniasis. The Medical Journal of Basrah University, 36(2), 97-102. doi: 10.33762/mjbu.2018.159464
Dindar S Qurtas. "Effect of Azithromycin in Treatment of Cutaneous Leishmaniasis". The Medical Journal of Basrah University, 36, 2, 2018, 97-102. doi: 10.33762/mjbu.2018.159464
(2018). 'Effect of Azithromycin in Treatment of Cutaneous Leishmaniasis', The Medical Journal of Basrah University, 36(2), pp. 97-102. doi: 10.33762/mjbu.2018.159464
Effect of Azithromycin in Treatment of Cutaneous Leishmaniasis. The Medical Journal of Basrah University, 2018; 36(2): 97-102. doi: 10.33762/mjbu.2018.159464
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 565
  • PDF Download: 398
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

 
This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus